These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 9581676
1. Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression. Saito H, Ebinuma H, Takahashi M, Kaneko F, Wakabayashi K, Nakamura M, Ishii H. Hepatology; 1998 May; 27(5):1233-40. PubMed ID: 9581676 [Abstract] [Full Text] [Related]
2. Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL. Emanuele S, D'Anneo A, Bellavia G, Vassallo B, Lauricella M, De Blasio A, Vento R, Tesoriere G. Eur J Cancer; 2004 Jun; 40(9):1441-52. PubMed ID: 15177505 [Abstract] [Full Text] [Related]
3. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer. Ramondetta L, Mills GB, Burke TW, Wolf JK. Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459 [Abstract] [Full Text] [Related]
4. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Jiang XH, Wong BC, Lin MC, Zhu GH, Kung HF, Jiang SH, Yang D, Lam SK. Oncogene; 2001 Nov 29; 20(55):8009-18. PubMed ID: 11753684 [Abstract] [Full Text] [Related]
5. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Park WH, Seol JG, Kim ES, Hyun JM, Jung CW, Lee CC, Kim BK, Lee YY. Cancer Res; 2000 Jun 01; 60(11):3065-71. PubMed ID: 10850458 [Abstract] [Full Text] [Related]
6. Induction of apoptosis in human gastric cancer by sodium butyrate. Litvak DA, Hwang KO, Evers BM, Townsend CM. Anticancer Res; 2000 Jun 01; 20(2A):779-84. PubMed ID: 10810354 [Abstract] [Full Text] [Related]
7. Characterization of the molecular mechanisms for p53-mediated differentiation. Chylicki K, Ehinger M, Svedberg H, Gullberg U. Cell Growth Differ; 2000 Nov 01; 11(11):561-71. PubMed ID: 11095245 [Abstract] [Full Text] [Related]
8. Sodium butyrate modulates p53 and Bcl-2 expression in human retinoblastoma cell lines. Madigan MC, Chaudhri G, Penfold PL, Conway RM. Oncol Res; 1999 Nov 01; 11(7):331-7. PubMed ID: 10757447 [Abstract] [Full Text] [Related]
9. Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells. Shieh DE, Chen YY, Yen MH, Chiang LC, Lin CC. Life Sci; 2004 Mar 19; 74(18):2279-90. PubMed ID: 14987952 [Abstract] [Full Text] [Related]
11. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53. Ramirez PT, Gershenson DM, Tortolero-Luna G, Ramondetta LM, Fightmaster D, Wharton JT, Wolf JK. Gynecol Oncol; 2001 Dec 19; 83(3):543-8. PubMed ID: 11733969 [Abstract] [Full Text] [Related]
12. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines. Ling YH, Liebes L, Jiang JD, Holland JF, Elliott PJ, Adams J, Muggia FM, Perez-Soler R. Clin Cancer Res; 2003 Mar 19; 9(3):1145-54. PubMed ID: 12631620 [Abstract] [Full Text] [Related]
13. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Giannakakou P, Robey R, Fojo T, Blagosklonny MV. Oncogene; 2001 Jun 28; 20(29):3806-13. PubMed ID: 11439344 [Abstract] [Full Text] [Related]
14. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Kokontis JM, Wagner AJ, O'Leary M, Liao S, Hay N. Oncogene; 2001 Feb 08; 20(6):659-68. PubMed ID: 11313999 [Abstract] [Full Text] [Related]
15. Ketoconazole induces G0/G1 arrest in human colorectal and hepatocellular carcinoma cell lines. Chen RJ, Lee WS, Liang YC, Lin JK, Wang YJ, Lin CH, Hsieh JY, Chaing CC, Ho YS. Toxicol Appl Pharmacol; 2000 Dec 01; 169(2):132-41. PubMed ID: 11097865 [Abstract] [Full Text] [Related]
16. Butyrate modulates DNA-damage-induced p53 response by induction of p53-independent differentiation and apoptosis. Janson W, Brandner G, Siegel J. Oncogene; 1997 Sep 18; 15(12):1395-406. PubMed ID: 9333015 [Abstract] [Full Text] [Related]
17. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells. Park SE, Lee SW, Hossain MA, Kim MY, Kim MN, Ahn EY, Park YC, Suh H, Kim GY, Choi YH, Kim ND. Cancer Lett; 2008 Oct 18; 270(1):77-86. PubMed ID: 18554781 [Abstract] [Full Text] [Related]
18. Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro. Lai PB, Chi TY, Chen GG. Apoptosis; 2007 Feb 18; 12(2):387-93. PubMed ID: 17191126 [Abstract] [Full Text] [Related]
19. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells. Drew L, Fine RL, Do TN, Douglas GP, Petrylak DP. Clin Cancer Res; 2002 Dec 18; 8(12):3922-32. PubMed ID: 12473608 [Abstract] [Full Text] [Related]
20. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin. Huang S, Liu LN, Hosoi H, Dilling MB, Shikata T, Houghton PJ. Cancer Res; 2001 Apr 15; 61(8):3373-81. PubMed ID: 11309295 [Abstract] [Full Text] [Related] Page: [Next] [New Search]